2021
DOI: 10.3390/jcm10132790
|View full text |Cite
|
Sign up to set email alerts
|

NecroX-5 Can Suppress Melanoma Metastasis by Reducing the Expression of Rho-Family GTPases

Abstract: NecroX-5 (NX-5) is a cell-permeable necrosis inhibitor with cytoprotective effects. Although it has been reported to inhibit lung and breast cancer metastasis by modulating migration, its therapeutic effect on melanoma metastasis is still unknown. In this study, we examined the anti-metastatic effect of NX-5 on melanoma cell lines and its related therapeutic mechanism. The anti-metastatic effect of NX-5 on melanoma cell lines was determined using a transwell migration assay. We performed a quantitative real-ti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…CCG‐1423 (APExBIO) selectively inhibits SRF‐mediated transcription of Rho signalling pathway activation 21 . Y‐27632 (AbMole Bioscience) is a pharmacologically specific inhibitor of ROCK 22 .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…CCG‐1423 (APExBIO) selectively inhibits SRF‐mediated transcription of Rho signalling pathway activation 21 . Y‐27632 (AbMole Bioscience) is a pharmacologically specific inhibitor of ROCK 22 .…”
Section: Methodsmentioning
confidence: 99%
“…CCG‐1423 (APExBIO) selectively inhibits SRF‐mediated transcription of Rho signalling pathway activation. 21 Y‐27632 (AbMole Bioscience) is a pharmacologically specific inhibitor of ROCK. 22 They were used to determine the regulatory role of RhoA/ROCK1 pathway in P. gingivalis infection cells.…”
Section: Methodsmentioning
confidence: 99%